Center-Authored Papers

Filters: Author is Deeg, H J  [Clear All Filters]
2017
Kekre N, Zhang Y, Zhang M-J, Carreras J, Ahmed P, Anderlini P, Atta EH, Ayas M, Boelens JJ, Bonfim C et al..  2017.  Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia.. Haematologica. Abstract
Dhawale T, Steuten LM, Deeg HJ.  2017.  Uncertainty of Physicians and Patients in Medical Decision Making.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Festuccia M, Baker K, Gooley TA, Sandmaier BM, Deeg HJ, Scott BL.  2017.  Hematopoietic Cell Transplantation in Myelodysplastic Syndromes after Treatment with Hypomethylating Agents.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Fenaux P, Giagounidis A, Selleslag D, Beyne-Rauzy O, Mittelman M, Muus P, Nimer SD, Hellström-Lindberg E, Powell BL, Guerci-Bresler A et al..  2017.  Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q).. Journal of hematology & oncology. 10(1):131. Abstract
Burroughs LM, Shimamura A, Talano J-A, Domm J, Baker K, Delaney C, Frangoul H, Margolis D, Baker KS, Geddis A et al..  2017.  Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Woo J, Howard NP, Storer BE, Fang M, Yeung CC, Scott BL, Deeg HJ.  2017.  Mutational analysis in serial marrow samples during azacitidine treatment in patients with post-transplant relapse of acute myeloid leukemia or myelodysplastic syndromes.. Haematologica. 102(6):e216-e218.
Bhagat T, Chen S, Bartenstein M, Barlowe TS, von Ahrens D, Choudhary GS, Tivnan P, Amin E, Marcondes AM, Sanders MA et al..  2017.  Wnt/ß-catenin activation by epigenetically aberrant stroma drives myelodysplastic syndrome.. Cancer research. Abstract
de Witte T, Bowen D, Robin M, Malcovati L, Niederwieser D, Yakoub-Agha I, Mufti GJ, Fenaux P, Sanz G, Martino R et al..  2017.  Use of hematopoietic cell transplantation for patients with myelodysplastic syndrome and chronic myelomonocytic leukemia.. Blood.
Zheng GXY, Terry JM, Belgrader P, Ryvkin P, Bent ZW, Wilson R, Ziraldo SB, Wheeler TD, McDermott GP, Zhu J et al..  2017.  Massively parallel digital transcriptional profiling of single cells.. Nature communications. 8:14049. Abstract
Greenberg PL, Stone RM, Al-Kali A, Barta SK, Bejar R, Bennett JM, Carraway H, De Castro CM, Deeg HJ, DeZern AE et al..  2017.  Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.. Journal of the National Comprehensive Cancer Network : JNCCN. 15(1):60-87. Abstract
Scott BL, Pasquini MC, Logan BR, Wu J, Devine SM, Porter DL, Maziarz RT, Warlick ED, Fernandez HF, Alyea EP et al..  2017.  Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 35(11):1154-1161. Abstract
2016
Milano F, Gooley T, Wood B, Woolfrey A, Flowers ME, Doney K, Witherspoon R, Mielcarek M, Deeg HJ, Sorror M et al..  2016.  Cord-Blood Transplantation in Patients with Minimal Residual Disease.. The New England journal of medicine. 375(10):944-53. Abstract
Yeung CCS, Deeg HJ, Pritchard C, Wu D, Fang M.  2016.  Jumping translocations in myelodysplastic syndromes.. Cancer genetics. 209(9):395-402. Abstract
Marcondes AM, Hockenbery D, Lesnikova M, Dinarello CA, Woolfrey A, Gernsheimer T, Loghman-Adham M, Gelmont D, Storer B, Hansen JA et al..  2016.  Response of Steroid-Refractory Acute GVHD to α1-Antitrypsin.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 22(9):1596-1601. Abstract
Woo J, Deeg HJ, Storer B, Yeung C, Fang M, Mielcarek M, Scott BL.  2016.  Factors Determining Responses to Azacitidine in Patients with MDS and AML with Early Post-Transplant Relapse: a Prospective Trial.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Karoopongse E, Marcondes AM, Yeung C, Holman Z, Kowdley KV, Campbell JS, Deeg HJ.  2016.  Disruption of Iron Regulation after Radiation and Donor Cell Infusion.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 22(7):1173-81. Abstract
Festuccia M, Deeg HJ, Gooley TA, Baker K, Wood BL, Fang M, Sandmaier BM, Scott BL.  2016.  Minimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Evolving from Myelodysplastic Syndrome.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 22(7):1227-33. Abstract
Mawad R, Becker PS, Hendrie P, Scott B, Wood BL, Dean C, Sandhu V, Deeg HJ, Walter R, Wang L et al..  2016.  Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS.. British journal of haematology. 172(2):238-245. Abstract
Vaughn JE, Anwer DF, Deeg HJ.  2016.  Treatment of refractory ITP and Evans syndrome by haematopoietic cell transplantation: is it indicated, and for whom? Vox sanguinis. 110(1):5-11. Abstract
Verstovsek S, Odenike O, Singer JW, Granston T, Al-Fayoumi S, Deeg HJ.  2016.  Phase 1/2 study of pacritinib, a next generation JAK2/FLT3 inhibitor, in myelofibrosis or other myeloid malignancies.. Journal of hematology & oncology. 9(1):137. Abstract
Ustun C, Gotlib J, Popat U, Artz A, Litzow M, Reiter A, Nakamura R, Kluin-Nelemans HC, Verstovsek S, Gajewski J et al..  2016.  Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 22(8):1348-1356. Abstract
2015
Kröger N, Giorgino T, Scott BL, Ditschkowski M, Alchalby H, Cervantes F, Vannucchi A, Cazzola M, Morra E, Zabelina T et al..  2015.  Impact of allogeneic stem cell transplantation on survival of patients less than 65 years with primary myelofibrosis.. Blood. 125(21):3347-50. Abstract
Kim E, Ilagan JO, Liang Y, Daubner GM, Lee SC-W, Ramakrishnan A, Li Y, Chung YR, Micol J-B, Murphy ME et al..  2015.  SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition.. Cancer cell. 27(5):617-30. Abstract
Au BKC, Gooley TA, Armand P, Fang M, Madtes DK, Sorror ML, Boeckh MJ, Gibson CJ, Deeg HJ, Storb R et al..  2015.  Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(5):848-54. Abstract
Greenberg PL, Stone RM, Bejar R, Bennett JM, Bloomfield CD, Borate U, De Castro CM, Deeg HJ, DeZern AE, Fathi AT et al..  2015.  Myelodysplastic syndromes, version 2.2015.. Journal of the National Comprehensive Cancer Network : JNCCN. 13(3):261-72. Abstract